Clinical Trials and Research Projects  
Vet Clinical Trials
VIN.com


Vet Clinical Trials

Search


Browse by category




Powered By VIN

 

Category: Neoplastic

Canine Mammary Tumors: Time to Second Tumor Investigation
June 7, 2006 (published)
Phil Bergman
You do not have permission to view this document: [5930855]!

Study Start Date: 06/12/2006

Canine Mammary Tumors: Time to Second Tumor Investigation

Dogs that are spayed later in life are at greatly increased risk for the subsequent development of mammary gland tumor (MGT). Dogs that develop a MGT are highly predisposed to developing subsequent MGT in other mammary sites ("field carcinogenesis" theory). We wish to delineate the median time to development of a 2nd MGT in dogs. This information will be used in the development of a clinical trial investigating possible chemopreventive properties of a commercially available compound.

Inclusion criteria:

  • Dogs with an initial histologically-confirmed diagnosis of MGT,
  • Dogs which develop a 2nd histologically proven MGT sometime AFTER the diagnosis of the 1st MGT

Exclusion Criteria:
Dogs that have not developed a 2nd MGT.

Survey Links:
If you are a Veterinary Cancer Society (VCS) and Veterinary Cooperative Oncology Group (VCOG) member (whether you are a VIN member or not), you can access the survey with this link: VCS MGT survey.
If you are not a VCS/VCOG member (but are a VIN member), please use this link: VIN MGT survey.

You do not have permission to view this document: [5930893]!

Full Disclosure information:

  • The study is unfunded, but supported by VIN. The investigators do not have any conflict of interest.
  • The study will be published if results are negative
  • The study will be reported on VIN
  • The authors will recognize, acknowledge or include VIN as a co-author if the study is published


Have questions or feedback? Email us